IL6 and COVID-19: Two recent studies in patients with COVID-19 showed a significant relationship between elevated IL-6 levels and hyponatremia (30, 44), supporting the concept of IL-6–related arginine vasopressin release in a subpopulation of COVID-19 patients who are at risk of cytokine storm and subsequent adverse clinical outcomes (45).